Evidence map›Paper›PMID 35320519›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Purification of Recombinant Galectins from Different Species Using Distinct Affinity Chromatography Methods.

Anu Paul, Shang-Chuen Wu, Kashyap R Patel, Alex D Ho, Jerry William Lynn Allen, Hans Verkerke, Connie M Arthur, Sean R Stowell

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anu Paul *Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Shang-Chuen Wu *Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Kashyap R PatelJoint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Alex D HoJoint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Jerry William Lynn AllenJoint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Hans VerkerkeJoint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Connie M ArthurJoint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sean R StowellJoint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. srstowell@bwh.harvard.edu.

Funding

Examining the Mechanisms of RBC Alloimmunization HyperrespondersR01HL154034 · NHLBI · EMORY UNIVERSITY · PI ARTHUR, CONNIE M · 2020 to 2024
$2.1M
Integrating microbial glycan arrays with genomic sequences to study host microbe interactionsU01CA242109 · NCI · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D, STOWELL, SEAN R · 2019 to 2021
$1.5M
NCI NIH HHS U01 CA242109NHLBI NIH HHS R01 HL154034
6 · The paper itself

Abstract

Galectins are lectins having the capacity to recognize β-galactose-containing glycan structures and are widely distributed among various taxa. However, the exact physiological and biochemical functions mediated by galectins that necessitate their wide occurrence among diverse species have not yet been delineated in a precise manner. Purification of recombinant galectins in active form is a fundamental requirement to elucidate their biological function. In this chapter, we are describing methods to recombinantly express and purify galectins using three different methods of affinity purification, i.e., lactosyl-Sepharose chromatography for fungal galectin Coprinopsis cinerea galectin 2 (CGL2), nickel-chromatography for histidine-tagged human galectin-7, and glutathione-Sepharose chromatography for Glutathione S-transferase-tagged (GST-tagged) human galectin-7. Step-by-step instructions are provided for obtaining the above-mentioned recombinant galectins that retain carbohydrate-binding activity and are suitable for conducting biochemical experiments.

Indexed as

Galectin 2GalectinsCarbohydratesChromatography, AffinityGalactoseHumansCarbohydratesGalactoseGalectin 2GalectinsCoprinopsis cinerea galectin-2 (CGL2)Divinyl sulfone-coupled lactosyl-SepharoseGlutathione-Sepharose affinity purification of GST-tagged human galectin-7Lactosyl-Sepharose affinity chromatographyNickel NTA-affinity purification of histidine-tagged human galectin-7Recombinant galectin purification

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.